Vaccine may provide a 'functional cure' for herpes

16:17 EDT 17 Oct 2016 | TriMed Media Group

Rational Vaccines, a biotechnology company and leaders in herpes research, have finished their Phase I Clinical Trial of the Theravax vaccine for patients with herpes simplex virus 1 and 2 (HSV-1, HSV-2). Results found that this medication may be the “functional cure” for both diseases.

Original Article: Vaccine may provide a 'functional cure' for herpes


More From BioPortfolio on "Vaccine may provide a 'functional cure' for herpes"

Quick Search

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...